Company
Abbvie
Abbvie is tracked across RERIGHT’s news graph. Explore its connections and the latest headlines below.
Latest on Abbvie
- STAT+: AbbVie wins FDA nod for Parkinson’s pill
- STAT+: Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts
- STAT+: AbbVie to buy Apogee Therapeutics in nearly $11B deal
- AbbVie buys Apogee for $10.9bn to acquire inflammatory disease drug
- Health Care Roundup: Market Talk
- Healthcare stocks have become a haven for investors ditching tech
- [via BlackRock]
- [via The Vanguard Group]
- Wikidata: Abbvie — led by — Richard A. Gonzalez
- Wikidata: Abbvie — capital ownership — The Vanguard Group
- Wikidata: Abbvie — led by — Robert A. Michael
- Wikidata: Abbvie — capital ownership — BlackRock
Connections
50 entities linked to Abbvie across the news graph.
Also connected to (50)
Boston Research & ManagementOld Mission Investment LlcAdvisors Asset ManagementB Riley Wealth AdvisorsEnvestnet Asset ManagementElm Partners Management LlcParrish Capital LlcPalogic Value Management L PWillow Creek Capital ManagementStokes Capital Advisors LlcMirador Capital Partners LpCapital Advisors Wealth Management LlcPaladin Partners LlcEastern BankAdelphi TrustCoastline TrustSTAT+: AbbVie wins FDA nod for Parkinson’s pillSTAT+: Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group assertsHealth Care Roundup: Market TalkHealthcare stocks have become a haven for investors ditching techSTAT+: AbbVie to buy Apogee Therapeutics in nearly $11B dealSTAT+: Another big deal, another sign biotech M&A is backGerald Baker Financial LlcParagon Capital Management